Brexit-related guidance for companies
Brexit-related guidance for companies
Brexit-related guidance for companies
Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use
List of signals discussed at PRAC since September 2012
New product information wording – Extracts from PRAC recommendations on signals adopted at the 27-30 November 2023 PRAC
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course, Online, from 18 June 2024 to 20 June 2024
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course, Online, from 21 February 2024 to 23 February 2024
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course, Online, from 22 April 2024 to 24 April 2024
Herbal medicinal product: Rosae flosArray,Array,Array, F: Assessment finalised
Herbal medicinal product: Sideritis herbaArray,Array,Array,Array, F: Assessment finalised
Herbal medicinal product: Pruni africanae cortexArray, F: Assessment finalised